Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,925 | -41,662 | -39,886 | -32,641 | -13,153 |
| Depreciation Amortization | 750 | 409 | 363 | 279 | 11 |
| Accounts payable and accrued liabilities | 564 | 84 | 2,349 | -644 | 671 |
| Other Working Capital | 6,779 | -1,071 | 443 | -792 | 170 |
| Other Operating Activity | 2,812 | 2,615 | -2,380 | 4,839 | 2,693 |
| Operating Cash Flow | $-50,020 | $-39,625 | $-39,111 | $-28,959 | $-9,608 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,844 | -80,720 | N/A | N/A | N/A |
| PPE Investments | -314 | -2,436 | -27 | -830 | -232 |
| Investing Cash Flow | $29,530 | $-83,156 | $-27 | $-830 | $-232 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,298 | 70,835 | 77,749 | 8,500 | 8,000 |
| Other Financing Activity | -158 | -1,312 | 38,362 | 25,913 | 7,275 |
| Financing Cash Flow | $16,140 | $69,523 | $116,111 | $34,413 | $15,275 |
| Beginning Cash Position | 34,080 | 87,338 | 10,365 | 5,741 | 256 |
| End Cash Position | 29,730 | 34,080 | 87,338 | 10,365 | 5,691 |
| Net Cash Flow | $-4,350 | $-53,258 | $76,973 | $4,624 | $5,435 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,020 | -39,625 | -39,111 | -28,959 | -9,608 |
| Capital Expenditure | -314 | -2,436 | -27 | -830 | -232 |
| Free Cash Flow | -50,334 | -42,061 | -39,138 | -29,789 | -9,840 |